Regulation of transglutaminases by nitric oxide

被引:31
作者
Bernassola, F [1 ]
Rossi, A [1 ]
Melino, G [1 ]
机构
[1] Univ Roma Tor Vergata, IDI, IRCCS, Biochem Lab,Dept Expt Med, I-00133 Rome, Italy
来源
MECHANISMS OF CELL DEATH: THE SECOND ANNUAL CONFERENCE OF THE CELL DEATH SOCIETY | 1999年 / 887卷
关键词
D O I
10.1111/j.1749-6632.1999.tb07924.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) is an inorganic diffusible molecular messenger that plays several central roles in pathophysiology. NO can affect the biological activity of proteins through the direct or indirect (via intermediate S-nitrosothiols) S-nitrosylation of protein thiol groups. Transglutaminases (TGases), Ca++-dependent enzymes that modify proteins by cross-linking reactions, require a cysteine residue in the active site as a prerequisite for their catalytic activity, Therefore, NO may regulate enzymatic activity of TGases and their biological effects, via S-nitrosylation of their crucial thiol groups, We here review the effects of NO on coagulation factor XIII (fXIII, or plasma TGase) and TGase 2 (or tissue transglutaminase), NO has an inhibitory effect on fXIII, thus suppressing the gamma-chain cross-linking in fibrin gels, and subsequent clot formation, Tissue transglutaminase, an apoptotic effector molecule, also represents a molecular target for NO. Accordingly, the inhibition of tissue transglutaminase enzymatic activity by NO is able to prevent the induction of apoptosis.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 43 条
[1]   Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes - Detection and identification of transglutaminase gene products based on reverse transcription polymerase chain reaction with degenerate primers [J].
Aeschlimann, D ;
Koeller, MK ;
Allen-Hoffmann, BL ;
Mosher, DF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3452-3460
[2]  
ANKARCRONA M, 1995, NEURON, V15, P1
[3]  
Bates JN, 1990, BIOCHEM PHARMACOL, V42, P157, DOI DOI 10.1016/0006-2952(91)90406-U
[4]   Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers [J].
Becker, K ;
Savvides, SN ;
Keese, M ;
Schirmer, RH ;
Karplus, PA .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :267-271
[5]   Inhibition of clotting factor XIII activity by nitric oxide [J].
Catani, MV ;
Bernassola, F ;
Rossi, A ;
Melino, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (01) :275-278
[6]   TRANSGLUTAMINASE FROM HAIR FOLLICLE OF GUINEA-PIG [J].
CHUNG, SI ;
FOLK, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (02) :303-+
[7]   Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases [J].
Dimmeler, S ;
Haendeler, J ;
Nehls, M ;
Zeiher, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :601-607
[8]   APOPTOTIC HEPATOCYTES BECOME INSOLUBLE IN DETERGENTS AND CHAOTROPIC AGENTS AS A RESULT OF TRANSGLUTAMINASE ACTION [J].
FESUS, L ;
THOMAZY, V ;
AUTUORI, F ;
CERU, MP ;
TARCSA, E ;
PIACENTINI, M .
FEBS LETTERS, 1989, 245 (1-2) :150-154
[9]   TRANSGLUTAMINASES [J].
FOLK, JE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1980, 49 :517-531
[10]  
GARBERS DL, 1992, CELL, V74, P1